2019, Number 2
<< Back Next >>
Rev Clin Esc Med 2019; 9 (2)
Disfunción ejecutiva en la Enfermedad de Huntington en fase preclínica versus fase clínica
Radulovich MM, González SM, Monge OJM
Language: Spanish
References: 8
Page: 77-83
PDF size: 497.30 Kb.
ABSTRACT
Huntington’s disease has been studied largely
by its motor symptomatology, but cognitive and
psychiatric affections appear to years before the
motor debut. Neuropsychiatric symptoms represent
an important load for patients and their families for
the loss of independence of those who suffer them.
The objective of this work is to carry out a research
of the specific cognitive symptoms that differ them
to carry out only the basic daily activities, the
references to the executive system. By identifying the
main affections of patients from early stages, a more
efficient therapeutic approach can be designed. The
review was carried out with studies of the last six
years, that were empirical studies and that included
patients with the grouped disease according to its
evolution. Within the studies used, different methods
of evaluation of the executive system applied. Both
psychiatric and cognitive symptoms are valued
within the executive function and how they evolve
in the course of disease. The results point out to an
important executive dysfunction from initial stages of
the disease, in particular an increased risk of apathy
since very early in the situation.
REFERENCES
Testa C M Jankovic J. Huntington disease: A quarter century of progress since the gene discovery. Journal of the Neurological Sciences, 2018, 396; 52-68.
Mörkl S Müller N J Blesl C Wilkinson L Tmava A Wurm W Painold A. Problem solving, impulse control and planning in patients with early- and latestage Huntington’s disease. European Archives of Psychiatry and Clinical Neuroscience, 2016, 266(7); 663-671.
Walker F O. Huntington’s disease. The Lancet, 2007, 369(9557); 218-228.
Domínguez D Poudel G Stout J C Gray M Chua P Borowsky B Georgiou-Karistianis N. Longitudinal changes in the fronto-striatal network are associated with executive dysfunction and behavioral dysregulation in Huntington’s disease: 30 months IMAGE-HD data. CORTEX. 2017; 92: 139-149.
Martínez-Horta S Perez-Perez J van Duijn E Fernandez-Bobadilla R Carceller M Pagonabarraga J Kulisevsky J Neuropsychiatric symptoms are very common in premanifest and early stage Huntington’s Disease. Parkinsonism & Related Disorders, 2016, 25; 58-64.
Unschuld P G Liu X Shanahan M Margolis L Bassett S S Brandt J Ross C A. Prefrontal executive function associated coupling relates to Hungtinton’s disease stage. CORTEX, 2013, 49(10); 2661-2673.
Maurage P Heeren A Lahaye M Jeanjean A Guettat L Verellen-Dumoulin C Constant E. Attentional impairments in Huntington’s disease: A specific deficit for the executive conflict. Neuropsychology, 2017, 31(4); 424-436.
Langbehn D R. Criteria for success in safety and tolerability trials. The Lancet Neurology, 2015; 14(1), 24-25.